• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载吉西他滨和紫杉醇的 cRGD 修饰的具有不对称脂质层的长循环纳米粒用于乳腺癌治疗。

Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.

机构信息

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.

State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.

出版信息

Molecules. 2018 Nov 7;23(11):2906. doi: 10.3390/molecules23112906.

DOI:10.3390/molecules23112906
PMID:30405089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6278289/
Abstract

Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginylglycylaspartic acid) peptide was introduced to the surface of lipid/calcium/phosphate (LCP) asymmetric lipid layer nanoparticles for the co-delivery of paclitaxel (PTX) and gemcitabine monophosphate (GMP) (P/G-NPs). The sphere-like morphology of P/G-NPs displays a well-distributed particle size, and high entrapment efficiency and drug loading for both PTX and GMP, with a positive zeta potential. P/G-NPs were stable for up to 15 days. The cellular uptake of these cyclic RGD-modified nanoparticles was significantly higher than that of unmodified nanoparticles over 2 h incubation. Compared with the combination of free PTX and GMP (P/G-Free), P/G-NPs exhibited a longer circulation lifetime and improved absorption for PTX and GMP. Polyethylene glycol was responsible for a higher plasma concentration and a decreased apparent volume of distribution (V). Nanoparticles enhanced the drug accumulation in tumors compared with other major organs after 24 h. P/G-NPs nearly halted tumor growth, with little evidence of general toxicity, whereas P/G-Free had only a modest inhibitory effect at 16 mg/kg of GMP and 2.0 mg/kg of PTX. Increased levels of apoptosis within tumors were detected in P/G-NPs group by approximately 43.6% (TUNEL assay). When compared with GMP NPs, PTX NPs, and P/G-Free, P/G-NPs decreased expression of B-cell lymphoma-2 and B-cell lymphoma-extra large proteins, and increased expression of cleaved poly-ADP-ribose polymerase-1. Calreticulin expression in tumors also increased upon the co-delivery of PTX and GMP. The antitumor effect of P/G-NPs is more powerful than P/G-Free, GMP NP, or PTX NP alone, without obvious toxicity.

摘要

联合化疗是癌症治疗中的一种常见临床实践。在这里,环状 RGD(精氨酰-甘氨酰-天冬氨酸)肽被引入脂质/钙/磷酸盐(LCP)不对称脂质层纳米粒子的表面,用于共递送紫杉醇(PTX)和单磷酸吉西他滨(GMP)(P/G-NPs)。P/G-NPs 的球型形态显示出均匀的粒径分布,以及对 PTX 和 GMP 均具有高包封效率和载药量,并带有正的 Zeta 电位。P/G-NPs 在长达 15 天内稳定。这些环状 RGD 修饰的纳米粒子的细胞摄取在 2 小时孵育期间明显高于未修饰的纳米粒子。与游离 PTX 和 GMP 的组合(P/G-Free)相比,P/G-NPs 表现出更长的循环寿命和改善的 PTX 和 GMP 吸收。聚乙二醇负责更高的血浆浓度和降低的表观分布容积(V)。与其他主要器官相比,纳米粒子增强了肿瘤中的药物积累。与 P/G-Free 相比,P/G-NPs 几乎停止了肿瘤生长,且毒性较小,而 P/G-Free 在 16mg/kg GMP 和 2.0mg/kg PTX 时仅具有适度的抑制作用。在 P/G-NPs 组中,通过大约 43.6%(TUNEL 测定)检测到肿瘤中凋亡的增加。与 GMP NPs、PTX NPs 和 P/G-Free 相比,P/G-NPs 降低了 B 细胞淋巴瘤-2 和 B 细胞淋巴瘤-额外大蛋白的表达,并增加了裂解多聚 ADP-核糖聚合酶-1 的表达。在共递送 PTX 和 GMP 时,肿瘤中钙网蛋白的表达也增加。与 P/G-Free、GMP NP 或 PTX NP 单独相比,P/G-NPs 的抗肿瘤作用更强,而没有明显的毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/196f52673b10/molecules-23-02906-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/123b4a023383/molecules-23-02906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/ec0459b500dc/molecules-23-02906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/2d043d012ea6/molecules-23-02906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/f7c60ac9a245/molecules-23-02906-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/ae2b31863be7/molecules-23-02906-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/f533187aaa6f/molecules-23-02906-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/6d97f8c73aed/molecules-23-02906-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/54f4f2d3cd48/molecules-23-02906-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/4d80194202e9/molecules-23-02906-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/cbe05bb220bc/molecules-23-02906-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/196f52673b10/molecules-23-02906-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/123b4a023383/molecules-23-02906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/ec0459b500dc/molecules-23-02906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/2d043d012ea6/molecules-23-02906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/f7c60ac9a245/molecules-23-02906-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/ae2b31863be7/molecules-23-02906-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/f533187aaa6f/molecules-23-02906-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/6d97f8c73aed/molecules-23-02906-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/54f4f2d3cd48/molecules-23-02906-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/4d80194202e9/molecules-23-02906-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/cbe05bb220bc/molecules-23-02906-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f53/6278289/196f52673b10/molecules-23-02906-g011.jpg

相似文献

1
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.载吉西他滨和紫杉醇的 cRGD 修饰的具有不对称脂质层的长循环纳米粒用于乳腺癌治疗。
Molecules. 2018 Nov 7;23(11):2906. doi: 10.3390/molecules23112906.
2
Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.甲氧基聚(乙二醇)-聚(丙交酯-乙交酯)-多肽纳米粒共递送紫杉醇和吉西他滨用于有效的乳腺癌治疗
Anticancer Drugs. 2018 Aug;29(7):637-645. doi: 10.1097/CAD.0000000000000631.
3
Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.合成一种修饰有吉西他滨的磷脂,并将其随后掺入到一种载紫杉醇的单微泡制剂中,用于使用超声靶向微泡破坏技术治疗胰腺癌。
Eur J Pharm Biopharm. 2021 Aug;165:374-382. doi: 10.1016/j.ejpb.2021.05.018. Epub 2021 May 24.
4
Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.含硫苷脂的全氟辛基溴化脂质纳米颗粒作为靶向乳腺癌的紫杉醇载体
Int J Nanomedicine. 2014 Aug 18;9:3971-85. doi: 10.2147/IJN.S67343. eCollection 2014.
5
RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.RGD 肽修饰的、紫杉醇前药为基础的、双药物负载的、氧化还原敏感的脂质-聚合物纳米粒用于增强肺癌治疗。
Biomed Pharmacother. 2018 Oct;106:275-284. doi: 10.1016/j.biopha.2018.06.137. Epub 2018 Jun 28.
6
Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.使用脂质包被的介孔二氧化硅纳米颗粒平台将吉西他滨和紫杉醇协同递送至小鼠的人胰腺癌中。
ACS Nano. 2015;9(4):3540-57. doi: 10.1021/acsnano.5b00510. Epub 2015 Mar 31.
7
Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.用于治疗胰腺癌的简便一锅法制备的载TRAIL的紫杉醇结合白蛋白纳米粒
Int J Pharm. 2015 Oct 15;494(1):506-15. doi: 10.1016/j.ijpharm.2015.08.055. Epub 2015 Aug 24.
8
Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.具有 pH 响应和聚乙二醇可分离特性的智能聚合物纳米粒,用于共递送紫杉醇和生存素 siRNA 以增强抗肿瘤效果。
Int J Nanomedicine. 2018 Apr 20;13:2405-2426. doi: 10.2147/IJN.S161426. eCollection 2018.
9
pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.用于在同基因小鼠实体瘤中进行抗癌药物递送的紫杉醇共轭聚(苯乙烯 - 共 - 马来酸)的pH敏感生物相容性纳米颗粒。
ACS Appl Mater Interfaces. 2015 Dec 9;7(48):26530-48. doi: 10.1021/acsami.5b07764. Epub 2015 Nov 23.
10
Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.基于二硫键连接的聚乙二醇-药物偶联物的新型载游离紫杉醇氧化还原响应性纳米颗粒用于细胞内药物递送:合成、表征及体内外抗肿瘤活性
Mol Pharm. 2014 Oct 6;11(10):3656-70. doi: 10.1021/mp500399j. Epub 2014 Sep 24.

引用本文的文献

1
Review on Electrospray Nanoparticles for Drug Delivery: Exploring Applications.用于药物递送的电喷雾纳米颗粒综述:探索应用
Polym Adv Technol. 2024 Jul;35(7). doi: 10.1002/pat.6507. Epub 2024 Jul 16.
2
Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy.靶向杂化纳米载体作为增强癌症治疗的共递送系统
Adv Pharm Bull. 2024 Oct;14(3):558-573. doi: 10.34172/apb.2024.046. Epub 2024 May 15.
3
RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect.RNA 纳米技术用于协同递高载核苷类似物治疗癌症。

本文引用的文献

1
cRGD functionalised nanocarriers for targeted delivery of bioactives.载有生物活性物质的靶向递药 cRGD 功能化纳米载体。
J Drug Target. 2019 Feb;27(2):111-124. doi: 10.1080/1061186X.2018.1473409. Epub 2018 May 23.
2
Calreticulin: a potential anti-cancer therapeutic target.钙网蛋白:一种潜在的抗癌治疗靶点。
Pharmazie. 2017 Sep 1;72(9):503-510. doi: 10.1691/ph.2017.7031.
3
Cancer statistics, 2018.癌症统计数据,2018 年。
Mol Pharm. 2024 Nov 4;21(11):5690-5702. doi: 10.1021/acs.molpharmaceut.4c00674. Epub 2024 Oct 10.
4
Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma.用于增强胰腺导管腺癌治疗反应的双载药肿瘤靶向聚合物纳米颗粒
Mater Today Bio. 2024 Aug 10;28:101199. doi: 10.1016/j.mtbio.2024.101199. eCollection 2024 Oct.
5
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression.含吉西他滨和紫杉醇的药物组合纳米颗粒可使原位4T1乳腺肿瘤消退。
Cancers (Basel). 2024 Aug 8;16(16):2792. doi: 10.3390/cancers16162792.
6
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety.新型姜黄素衍生物修饰的超长效循环紫杉醇纳米粒子:一种具有优异抗癌疗效和安全性的新型给药系统。
Int J Nanomedicine. 2022 Nov 14;17:5265-5286. doi: 10.2147/IJN.S369761. eCollection 2022.
7
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice.化疗在乳腺癌中的免疫刺激作用:从免疫原性调节机制到临床实践。
Front Immunol. 2022 Jan 5;12:819405. doi: 10.3389/fimmu.2021.819405. eCollection 2021.
8
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.转移性乳腺癌治疗中的挑战和机遇:优先递送至转移性细胞的纳米药物组合可能会增强治疗反应。
Pharmacol Ther. 2022 Aug;236:108108. doi: 10.1016/j.pharmthera.2022.108108. Epub 2022 Jan 6.
9
Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.刺激响应型纳米载体在基因治疗中的最新进展。
Adv Sci (Weinh). 2021 May 16;8(14):2100540. doi: 10.1002/advs.202100540. eCollection 2021 Jul.
10
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.转移性乳腺癌的耐药性:肿瘤靶向纳米医学的救援。
Int J Mol Sci. 2021 Apr 28;22(9):4673. doi: 10.3390/ijms22094673.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.脂质包覆的磷酸钙纳米颗粒及其应用:药物递送的多功能平台。
J Drug Target. 2018 Jun-Jul;26(5-6):398-406. doi: 10.1080/1061186X.2017.1419360. Epub 2017 Dec 27.
5
Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.混合脂质体方法用于紫杉醇和吉西他滨的比率和顺序递药。
AAPS PharmSciTech. 2018 Feb;19(2):693-699. doi: 10.1208/s12249-017-0877-z. Epub 2017 Oct 2.
6
Exploring the Role of RGD-Recognizing Integrins in Cancer.探索RGD识别整合素在癌症中的作用。
Cancers (Basel). 2017 Sep 4;9(9):116. doi: 10.3390/cancers9090116.
7
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.吉西他滨增强纳米载体结合白蛋白紫杉醇在吉西他滨耐药性胰腺导管腺癌中的转运。
Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.
8
iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.负载异甘草素的iRGD修饰脂质-聚合物杂化纳米粒增强抗乳腺癌效果及肿瘤靶向能力。
Int J Nanomedicine. 2017 Jun 1;12:4147-4162. doi: 10.2147/IJN.S134148. eCollection 2017.
9
Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.基于组合纳米载体的药物传递方法在乳腺癌细胞中联合应用抗肿瘤药物:一种改进的纳米医学策略。
Sci Rep. 2016 Oct 11;6:34053. doi: 10.1038/srep34053.
10
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.不同长循环材料对硫酸长春新碱脂质体药代动力学的影响。
Int J Nanomedicine. 2016 Aug 26;11:4187-97. doi: 10.2147/IJN.S109547. eCollection 2016.